SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-039286
Filing Date
2021-07-29
Accepted
2021-07-29 16:02:59
Documents
58
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_lanternpharma.htm   iXBRL 10-Q 906897
2 CERTIFICATION f10q0621ex31-1_lanternpharma.htm EX-31.1 16220
3 CERTIFICATION f10q0621ex31-2_lanternpharma.htm EX-31.2 14324
4 CERTIFICATION f10q0621ex32-1_lanternpharma.htm EX-32.1 4816
5 CERTIFICATION f10q0621ex32-2_lanternpharma.htm EX-32.2 4475
  Complete submission text file 0001213900-21-039286.txt   4188575

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ltrn-20210630.xsd EX-101.SCH 46998
7 XBRL CALCULATION FILE ltrn-20210630_cal.xml EX-101.CAL 23621
8 XBRL DEFINITION FILE ltrn-20210630_def.xml EX-101.DEF 187334
9 XBRL LABEL FILE ltrn-20210630_lab.xml EX-101.LAB 368497
10 XBRL PRESENTATION FILE ltrn-20210630_pre.xml EX-101.PRE 195472
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_lanternpharma_htm.xml XML 514541
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39318 | Film No.: 211127341
SIC: 2834 Pharmaceutical Preparations